Araclon Biotech’s Alzheimer’s vaccine ABvac40 is going forward into Phase II after showing a good safety...
Up To Date
Latest News
After a two-year pilot period, the EMA has published its report on its adaptive pathways approach. The agency...
Life science venture capital group Epidarex has launched Nodthera Ltd, a biotech based on research by...
GlaxoSmithKline has in-licensed Janssen’s anti-IL-33R monoclonal antibody for severe asthma. The British...
In view of the Brexit, research academies across Britain are calling for a “bold commitment” from the...
Belgian molecular diagnostics company Biocartis Group NV has raised €55m and will use the funds mainly to...